Olopatadine Misom (Olopatadine)

Olopatadine blocks histamine H1 receptors on ocular cells and stabilizes mast cells, preventing the release of histamine and other inflammatory mediators. This dual action reduces vascular dilation and cellular inflammation, providing rapid relief of allergic eye symptoms.

The appropriate dose of Olopatadine Misom is determined by the prescribing healthcare professional based on the patient’s condition and response. Typically, one drop is instilled in the affected eye(s) as directed, but exact dosing should follow the prescriber’s instructions.

Safety data for Olopatadine Misom in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this medication.

To order Olopatadine Misom, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Olopatadine Misom combines antihistamine and mast‑cell‑stabilizing actions, offering both rapid symptom relief and longer‑term control. Compared with single‑action antihistamine drops, it may provide more sustained benefit, while its safety profile is similar to other topical antihistamines.

Olopatadine Misom should be stored at room temperature, below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from light and moisture, and discard any solution that appears discolored or contains particles.

Olopatadine Misom is applied topically to the eye. The patient should wash hands, tilt the head back, pull down the lower eyelid, and place one drop into the conjunctival sac. The eye should be closed gently for a few seconds to allow absorption.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, corneal ulceration, increased intra‑ocular pressure, and persistent eye pain. Patients should seek immediate medical attention if they experience sudden vision loss, severe pain, or swelling.

Olopatadine Misom should be avoided in individuals with known hypersensitivity to olopatadine or any component of the formulation. It is also contraindicated in patients with active ocular infections until the infection is resolved.